| Manreet Basra, MD | |
|
1801 E March Ln Ste D400, Stockton, CA 95210-6675 | |
| (209) 464-3615 | |
| Not Available |
| Full Name | Manreet Basra |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 1801 E March Ln Ste D400, Stockton, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114157484 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Lodi Memorial | Lodi, CA | Hospital |
| St Joseph's Medical Center Of Stockton | Stockton, CA | Hospital |
| Dameron Hospital | Stockton, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Health Physicians Network | 3274580972 | 499 |
News Archive
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.
How best to treat and recover from complicated hip injuries is a growing field in orthopaedic medicine. While diagnostic hip injections are commonly performed for patients with labral tear to confirm the pain etiology, research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day suggests that pain relief from this diagnostic injection may not predict better outcomes following arthroscopic hip surgery.
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a two-year clinical study aiming to advance the acceptance of new biomarkers designed to detect drug-induced kidney injury in clinical trials.
Five Indiana University School of Medicine geriatricians are among only 83 advanced fellows and junior faculty members nationwide who will share in $2.5 million in career development awards from The John A. Hartford Foundation.
› Verified 2 days ago
| Entity Name | Pacific Heart And Vascular Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649208463 PECOS PAC ID: 1658267190 Enrollment ID: O20040223001067 |
News Archive
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.
How best to treat and recover from complicated hip injuries is a growing field in orthopaedic medicine. While diagnostic hip injections are commonly performed for patients with labral tear to confirm the pain etiology, research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day suggests that pain relief from this diagnostic injection may not predict better outcomes following arthroscopic hip surgery.
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a two-year clinical study aiming to advance the acceptance of new biomarkers designed to detect drug-induced kidney injury in clinical trials.
Five Indiana University School of Medicine geriatricians are among only 83 advanced fellows and junior faculty members nationwide who will share in $2.5 million in career development awards from The John A. Hartford Foundation.
› Verified 2 days ago
| Entity Name | Adventist Health Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063718583 PECOS PAC ID: 3274580972 Enrollment ID: O20050407000633 |
News Archive
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.
How best to treat and recover from complicated hip injuries is a growing field in orthopaedic medicine. While diagnostic hip injections are commonly performed for patients with labral tear to confirm the pain etiology, research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day suggests that pain relief from this diagnostic injection may not predict better outcomes following arthroscopic hip surgery.
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a two-year clinical study aiming to advance the acceptance of new biomarkers designed to detect drug-induced kidney injury in clinical trials.
Five Indiana University School of Medicine geriatricians are among only 83 advanced fellows and junior faculty members nationwide who will share in $2.5 million in career development awards from The John A. Hartford Foundation.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Manreet Basra, MD 1801 E March Ln Ste D400, Stockton, CA 95210-6675 Ph: (209) 464-3615 | Manreet Basra, MD 1801 E March Ln Ste D400, Stockton, CA 95210-6675 Ph: (209) 464-3615 |
News Archive
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.
How best to treat and recover from complicated hip injuries is a growing field in orthopaedic medicine. While diagnostic hip injections are commonly performed for patients with labral tear to confirm the pain etiology, research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day suggests that pain relief from this diagnostic injection may not predict better outcomes following arthroscopic hip surgery.
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a two-year clinical study aiming to advance the acceptance of new biomarkers designed to detect drug-induced kidney injury in clinical trials.
Five Indiana University School of Medicine geriatricians are among only 83 advanced fellows and junior faculty members nationwide who will share in $2.5 million in career development awards from The John A. Hartford Foundation.
› Verified 2 days ago
Jasmine Hundal, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7210 Murray Dr, Stockton, CA 95210 Phone: 209-751-1919 | |
Dr. Navneet Kaur, M.B.B.S Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1805 N California St Ste 201, Stockton, CA 95204 Phone: 209-645-4005 Fax: 209-645-6344 | |
David C Lim, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 E Harding Way, Suite D, Stockton, CA 95204 Phone: 209-944-5750 | |
Xing-jian Lu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7373 West Ln, Stockton, CA 95210 Phone: 209-476-2000 | |
Kwabena Opoku-mensah Adubofour, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2524 E Main St, Stockton, CA 95205 Phone: 800-249-9497 Fax: 800-249-9497 | |
Dr. Ronald A Kass, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1801 E March Ln Ste C310, Stockton, CA 95210 Phone: 209-465-5731 Fax: 209-465-0230 | |
Issa M. Fakhouri, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 7373 West Ln, Stockton, CA 95210 Phone: 209-476-2000 |